Fernandez, Emilio L.
HRN: 03-66-60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/04/2025
06/11/2025
IV
600mg
Q8h
CAP MR; Pressure Sores
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes